Emerging Markets Earnings Roundup: Bayer And AbbVie: Part 5
This article was originally published in PharmAsia News
Executive Summary
While Bayer saw a slowdown in Q2 in China, AbbVie says a particular genotype gives it an edge in Japan’s hepatitis C market.